Structure Therapeutics
GPCR
GPCR
195 hedge funds and large institutions have $3.22B invested in Structure Therapeutics in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 73 increasing their positions, 58 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14.16% less ownership
Funds ownership: 108.4% → 94.24% (-14%)
30% less capital invested
Capital invested by funds: $4.58B → $3.22B (-$1.36B)
63% less funds holding in top 10
Funds holding in top 10: 16 → 6 (-10)
Holders
195
Holding in Top 10
6
Calls
$27.4M
Puts
$18.9M
Top Buyers
| 1 | +$63.7M | |
| 2 | +$37.3M | |
| 3 | +$32.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.6M |
| 5 |
O
OrbiMed
New York
|
+$21.5M |
Top Sellers
| 1 | -$53.4M | |
| 2 | -$52.9M | |
| 3 | -$34.9M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$31.6M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$23.3M |
